This opinion was underlined by negative advice for CPT2 deficiency from the Dutch Health Council, based on the large phenotypic variation [34], and this was seconded in very recent negative advice by the ANS-IMD (June 2024) based on the consideration that all (Dutch) patients found were adults. The gene discussed is CPT2; the disease is hyperinsulinemic hypoglycemia, familial, 4.